TrialNature medicine2022

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.

Lacey J Padrón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.